Marco Binder (M Binder)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Nature biotechnology

PLoS computational biology

PLoS pathogens

EMBO reports

Deutsches Krebsforschungszentrum

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Deutsches Krebsforschungszentrum Mar 01 2014

Germany

Group Leader "Dynamics of early viral infection and the innate antiviral response" :: Virus-Associated Carcinogenesis (F170)

Ruprecht Karls Universität Heidelberg Medizinische Fakultät Heidelberg Jan 01 2011 - Feb 28 2014

Germany

Group Leader :: Infectious Diseases, Molecular Virology

Ruprecht Karls Universität Heidelberg Medizinische Fakultät Heidelberg Jan 01 2009 - Dec 31 2010

Germany

Postdoctorial Fellowship (Award) for young researchers / group leaders :: Infectious Diseases, Molecular Virology

Ruprecht Karls Universität Heidelberg Medizinische Fakultät Heidelberg Sep 01 2007 - Dec 31 2008

Germany

PostDoc :: Infectious Diseases, Molecular Virology

Publications

Sevinj Sultanli, Jakob Schneider, Sandy S Burkart, Marco Binder, Katharina F Kubatzky
Cellular ROS tolerance determines the effect of plumbagin on osteoclast differentiation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (12) (2023)
Vladimir G Magalhães, Sören Lukassen, Maike Drechsler, Jennifer Loske, Sandy S Burkart, Sandra Wüst, Eva-Maria Jacobsen, Jobst Röhmel, Marcus Alexander Mall, Klaus-Michael Debatin, Roland Eils, Stella E Autenrieth, Ales Janda, Irina Lehmann, Marco Binder
Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children. EMBO reports (2023)
Sandy S Burkart, Darius Schweinoch, Jamie Frankish, Carola Sparn, Sandra Wüst, Christian Urban, Marta Merlo, Vladimir G Magalhães, Antonio Piras, Andreas Pichlmair, Joschka Willemsen, Lars Kaderali, Marco Binder
High-resolution kinetic characterization of the RIG-I-signaling pathway and the antiviral response. Life science alliance 6 (10) (2023)
David Y Zander, Sandy S Burkart, Sandra Wüst, Vladimir G Magalhães, Marco Binder
Cooperative effects of RIG-I-like receptor signaling and IRF1 on DNA damage-induced cell death. Cell death & disease 13 (4) (2022)
Benjamin Dominik Maier, Luis U Aguilera, Sven Sahle, Pascal Mutz, Priyata Kalra, Christopher Dächert, Ralf Bartenschlager, Marco Binder, Ursula Kummer
Stochastic dynamics of Type-I interferon responses. PLoS computational biology 18 (10) (2022)
Jennifer Loske, J Röhmel, Soeren Lukassen, S Stricker, V G Magalhães, Johannes Liebig, Robert Lorenz Chua, Loreen Thürmann, Marey Messingschlager, A Seegebarth, B Timmermann, S Klages, M Ralser, Birgit Sawitzki, Leif-Erik Sander, Victor Max Corman, C Conrad, Sven Laudi, Marco Binder, Saskia Trump, Roland Eils, Marcus Alexander Mall, Irina Lehmann
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nature biotechnology (2021)
Sandra Wüst, Paulina Schad, Sandy S Burkart, Marco Binder
Comparative Analysis of Six IRF Family Members in Alveolar Epithelial Cell-Intrinsic Antiviral Responses. Cells 10 (10) (2021)
Beatrice T Laudenbach, Karsten Krey, Quirin Emslander, Line Lykke Andersen, Alexander Reim, Pietro Scaturro, Sarah Mundigl, Christopher Dächert, Katrin Manske, Markus Moser, Janos Ludwig, Dirk Wohlleber, Andrea Kröger, Marco Binder, Andreas Pichlmair
NUDT2 initiates viral RNA degradation by removal of 5'-phosphates. Nature communications 12 (1) (2021)
Agnieszka Plociennikowska, Jamie Frankish, Thais Moraes, Dolores Del Prete, Franziska Kahnt, Claudio Acuna, Michal Slezak, Marco Binder, Ralf F W Bartenschlager
TLR3 activation by Zika virus stimulates inflammatory cytokine production which dampens the antiviral response induced by RIG-I-like receptors. Journal of virology (2021)
Simon Dirmeier, Christopher Daechert, Martijn J van Hemert, Ali Tas, Natacha S Ogando, Frank J M van Kuppeveld, Ralf F W Bartenschlager, Lars Kaderali, Marco Binder, Niko Beerenwinkel
Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation. PLoS computational biology 16 (2) (2020)
Saskia Trump, Soeren Lukassen, Markus S Anker, Robert Lorenz Chua, Johannes Liebig, Loreen Thürmann, Victor Max Corman, Marco Binder, Jennifer Loske, Christina Klasa, Teresa Krieger, Bianca P Hennig, Marey Messingschlager, Fabian Höing, Julia Kazmierski, Sven Twardziok, Jan Philipp Albrecht, Jürgen Eils, Sara Hadzibegovic, Alessia Lena, Bettina Heidecker, Thore Bürgel, Jakob Steinfeldt, Christine Goffinet, Florian Kurth, Martin Witzenrath, Maria Theresa Völker, Sarah Dorothea Müller, Uwe Gerd Liebert, Naveed Ishaque, Lars Kaderali, Leif-Erik Sander, Christian Drosten, Sven Laudi, Roland Eils, Christian Conrad, Ulf Landmesser, Irina Lehmann
Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nature biotechnology 39 (6) (2020)
Katharina Robichon, Tim Maiwald, Marcel Schilling, Annette Schneider, Joschka Willemsen, Florian Salopiata, Melissa Teusel, Clemens Kreutz, Christian Ehlting, Jun Huang, Sajib Chakraborty, Xiaoyun Huang, Georg Damm, Daniel Seehofer, Philipp A Lang, Johannes G Bode, Marco Binder, Ralf F W Bartenschlager, Jens Timmer, Ursula Klingmüller
Identification of Interleukin1β as an Amplifier of Interferon alpha-induced Antiviral Responses. PLoS pathogens 16 (10) (2020)
Christopher Daechert, Evgeny Gladilin, Marco Binder
Gene Expression Profiling of Different Huh7 Variants Reveals Novel Hepatitis C Virus Host Factors. Viruses 12 (1) (2019)

Marco Binder.css-eqlu8i{font-size:small;padding-left:4px;} (M Binder)

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Binder (M Binder)